
Penumbra PEN
$ 329.13
0.13%
Quarterly report 2026-Q1
added 05-06-2026
Penumbra P/E Ratio 2011-2026 | PEN
Annual P/E Ratio Penumbra
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 74.3 | 744 | 111 | -4.94 K | 1.54 K | -648 | 128 | 739 | 718 | 146 | 217 | 6.06 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.54 K | -4.94 K | -97.1 |
P/E Ratio of other stocks in the Medical devices industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
-50 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
-0.142 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-47.3 | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
-0.108 | - | - | $ 10.2 M | ||
|
Lianluo Smart Limited
LLIT
|
-45.2 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
-2.07 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-2.84 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
-12.4 | $ 11.68 | 2.05 % | $ 331 M | ||
|
Apollo Endosurgery
APEN
|
-10.1 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
-14.4 | $ 8.26 | -0.18 % | $ 1.24 B | ||
|
Aziyo Biologics
AZYO
|
-0.714 | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
-3.16 | $ 4.36 | 1.28 % | $ 163 M | ||
|
BioSig Technologies
BSGM
|
-0.707 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-0.00929 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
-0.25 | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
-15.9 | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
-98.5 | $ 2.29 | - | $ 50.5 M | ||
|
CryoLife, Inc.
CRY
|
-54.3 | - | -4.14 % | $ 702 M | ||
|
IRIDEX Corporation
IRIX
|
-3.74 | $ 1.02 | 0.79 % | $ 17.3 M | ||
|
CHF Solutions, Inc.
CHFS
|
-0.0578 | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
-4.25 | $ 0.48 | 4.14 % | $ 29.9 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-11 | $ 17.9 | -2.56 % | $ 420 M | ||
|
Delcath Systems
DCTH
|
121 | $ 10.97 | -0.45 % | $ 393 M | ||
|
Soliton, Inc.
SOLY
|
-15.7 | - | -1.42 % | $ 435 M | ||
|
LENSAR
LNSR
|
-2.08 | $ 6.05 | -0.74 % | $ 72.3 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-875 | - | -1.98 % | $ 98.3 M | ||
|
LivaNova PLC
LIVN
|
-15.7 | $ 75.17 | 1.81 % | $ 4.1 B | ||
|
Itamar Medical Ltd.
ITMR
|
-31 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-10.6 | - | - | $ 462 M | ||
|
Pulmonx Corporation
LUNG
|
-1.35 | $ 1.52 | -2.26 % | $ 61.8 M | ||
|
Neovasc
NVCN
|
-27.2 | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
-0.179 | - | 14.99 % | $ 929 K | ||
|
MiMedx Group
MDXG
|
16 | $ 3.69 | 1.8 % | $ 545 M | ||
|
Electromed
ELMD
|
23.2 | $ 37.15 | -2.8 % | $ 314 M | ||
|
Myomo
MYO
|
-2.17 | $ 1.03 | -0.48 % | $ 43.1 M | ||
|
Butterfly Network
BFLY
|
-12.3 | $ 4.6 | 2.8 % | $ 1.14 B | ||
|
Intersect ENT, Inc.
XENT
|
-10.2 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
9.6 | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
-5.33 | $ 9.62 | -10.51 % | $ 381 M | ||
|
GBS
GBS
|
-0.235 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
23.2 | $ 85.36 | 0.65 % | $ 11.5 B | ||
|
Profound Medical Corp.
PROF
|
-3.9 | $ 6.86 | 0.44 % | $ 207 M | ||
|
Insulet Corporation
PODD
|
73.4 | $ 155.0 | 0.08 % | $ 10.9 B | ||
|
CONMED Corporation
CNMD
|
28 | $ 35.96 | -3.41 % | $ 1.12 B | ||
|
Sintx Technologies
SINT
|
-0.666 | $ 2.44 | 2.09 % | $ 6.77 M | ||
|
Inspire Medical Systems
INSP
|
12.1 | $ 42.74 | -2.51 % | $ 1.26 B | ||
|
Integer Holdings Corporation
ITGR
|
29 | $ 89.8 | 0.58 % | $ 3.12 B | ||
|
Invacare Corporation
IVC
|
-1.17 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
45.5 | $ 87.37 | 1.85 % | $ 51.1 B | ||
|
TransMedics Group
TMDX
|
24.7 | $ 69.63 | 1.01 % | $ 2.37 B |